Stambler, B. S., Camm, A. J., Piccini, J. P., Bharucha, D. B., Ip, J. E., & coauthors from the RAPID Trial. (2025). Safety of intranasally administered etripamil: RAPID trial update. Lancet, 405(10490), 1662–1663. https://doi.org/10.1016/S0140-6736(25)00545-8

Stambler, Bruce S., A John Camm, Jonathan P. Piccini, David B. Bharucha, James E. Ip, and coauthors from the RAPID Trial. “Safety of intranasally administered etripamil: RAPID trial update.” Lancet 405, no. 10490 (May 10, 2025): 1662–63. https://doi.org/10.1016/S0140-6736(25)00545-8.

Stambler BS, Camm AJ, Piccini JP, Bharucha DB, Ip JE, coauthors from the RAPID Trial. Safety of intranasally administered etripamil: RAPID trial update. Lancet. 2025 May 10;405(10490):1662–3.

Stambler, Bruce S., et al. “Safety of intranasally administered etripamil: RAPID trial update.” Lancet, vol. 405, no. 10490, May 2025, pp. 1662–63. Pubmed, doi:10.1016/S0140-6736(25)00545-8.

Stambler BS, Camm AJ, Piccini JP, Bharucha DB, Ip JE, coauthors from the RAPID Trial. Safety of intranasally administered etripamil: RAPID trial update. Lancet. 2025 May 10;405(10490):1662–1663.